Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Institut Fuer Ernaehrung Und Praevention GmbH currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, ESSEX, LAURA ANN. The prosecution is localized in a distinct art unit, indicating a specialized technical focus. ESSEX, LAURA ANN is the busiest examiner, managing the busiest examiner pending action.
With 1 distinct examiner and a distinct art unit, the current prosecution effort is highly concentrated. This 1 pending office action is the only matter currently requiring attention from the patent office for this portfolio. The assignment to a distinct art unit suggests that the technology involved is specialized and falls under a specific examination group.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ESSEX, LAURA ANN | 1 | 60.0% | +35.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17056663 | PHARMACEUTICAL PREPARATION FOR USE IN TREATING EPSTEIN- BARR VIRUS POSITIVE PATIENTS WITH REACTIVATION PHENOMENON- ASSOCIATED DISEASES | ESSEX, LAURA ANN | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17056663 | PHARMACEUTICAL PREPARATION FOR USE IN TREATING EPSTEIN- BARR VIRUS POSITIVE PATIENTS WITH REACTIVATION PHENOMENON- ASSOCIATED DISEASES | ESSEX, LAURA ANN | 1675 | §103 | Final Rejection | — | Pending | Nov 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitut Fuer Ernaehrung Und Praevention GmbH has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Laura Ann Essex has the most, with 1 of Institut Fuer Ernaehrung Und Praevention GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
